Multicenter Biologic Assignment Trial Comparing Reduced-Intensity Allogeneic Hematopoietic Cell Transplant to Hypomethylating Therapy or Best Supportive Care in Patients Aged 50 to 75 with Intermediate-2 and High-Risk Myelodysplastic Syndrome: Blood and Marrow Transplant Clinical Trials Network #1102 Study Rationale, Design, and Methods
Titel:
Multicenter Biologic Assignment Trial Comparing Reduced-Intensity Allogeneic Hematopoietic Cell Transplant to Hypomethylating Therapy or Best Supportive Care in Patients Aged 50 to 75 with Intermediate-2 and High-Risk Myelodysplastic Syndrome: Blood and Marrow Transplant Clinical Trials Network #1102 Study Rationale, Design, and Methods
Auteur:
Saber, Wael Le Rademacher, Jennifer Sekeres, Mikkael Logan, Brent Lewis, Moira Mendizabal, Adam Leifer, Eric Appelbaum, Frederick R. Horowitz, Mary M. Nakamura, Ryotaro Cutler, Corey S.
Verschenen in:
Biology of blood and marrow transplantation
Paginering:
Jaargang 20 (2014) nr. 10 pagina's 7 p.
Jaar:
2014
Inhoud:
Uitgever:
American Society for Blood and Marrow Transplantation